VKH
AMPH icon

Virtu KCG Holdings’s Amphastar Pharmaceuticals AMPH Stock Holding History

Virtu KCG Holdings’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-14,690
Closed -$271K – 3094
2016
Q4 		$271K Buy
+14,690
New +$286K 0.01% 2220
2015
Q4 		– Sell
-15,263
Closed -$178K – 3460
2015
Q3 		$178K Buy
+15,263
New +$229K ﹤0.01% 2617

Other funds holding AMPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
RCAMU
Rothschild & Co Asset Management US Stamford, Connecticut $6.58B AUM 4.5% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
TA
Teachers Advisors New York $81.7B AUM 13.62% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Virtu KCG Holdings's AMPH Position: Q1 2017 in Review

Virtu KCG Holdings sold out of Amphastar Pharmaceuticals (AMPH) in Q1 2017, closing a stake of 14,690 shares — an estimated $271K sold.

Virtu KCG Holdings first reported a position in AMPH in Q3 2015 and held it in 2 quarters. The position peaked at $271K in Q4 2016. 116 funds tracked by Wall St. Rank hold AMPH as of Q1 2017.

  • Virtu KCG Holdings reported no remaining Amphastar Pharmaceuticals position as of Q1 2017 after selling out during the quarter.
  • Virtu KCG Holdings sold 14,690 Amphastar Pharmaceuticals shares in Q1 2017, an estimated $271K.
  • Virtu KCG Holdings first reported a position in Amphastar Pharmaceuticals in Q3 2015 and held it in 2 quarters.
  • Virtu KCG Holdings's Amphastar Pharmaceuticals position peaked at $271K in Q4 2016.
  • 116 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q1 2017.

Based on Virtu KCG Holdings's 13F filing for Q1 2017, filed 12 May 2017.